AI assistant
Grieg Seafood — Investor Presentation 2021
Aug 18, 2021
3612_rns_2021-08-18_f5ac3f44-2913-433b-832b-7cf3a002d3b7.pdf
Investor Presentation
Open in viewerOpens in your device viewer
Q2 2021
Agenda
- HIGHLIGHTS
- OPERATIONAL REVIEW
- FINANCIAL REVIEW
- OUTLOOK & CONCLUDING REMARKS
Q2 2021
Highlights Q2 2021
- EBIT before production fee and fair value adjustment of NOK 44 million (47 million)
- Downgrades, harvest weight and harvest profile impacted price achievement in Finnmark by NOK -41 million
- Operational cost in Newfoundland, including write down related to ISA, of NOK -45 million
- Strong production and good price achievement in British Columbia
- Agreement to sell Shetland operations for GBP 164 million
- Good performance in Shetland following restructuring and operational improvement, EBITDA of NOK 56 million (held for sale)
- Underlying operational improvement, expect lower costs towards year end and through 2022
- Integrated sales and market organization handling 100% of sold volume in the quarter
18.08.2021 Harvest volume and revenues for Q2 20 through Q2 21 reflect Grieg Seafood's revenues exclusive of the discontinued operations of Shetland (and Ocean Quality for 2020). EBIT-figures are before production fee and fair value adjustment of biological assets. EBIT/kg Q2 20 through Q2 21 is calculated based on Group EBIT before production fee and fair value adjustment of biological assets ex. Shetland, and the Group's harvest volume ex. Shetland.
3
Agreement to sell Shetland
- Agreement with Scottish Sea Farms to sell GSF Shetland for GBP 164 million
- Shetland operations showing good performance following extensive restructuring and operational improvements
- Transaction approved by EU competition authorities awaiting approval from UK authorities
- Expect to close within Q4 2021
- Concentrating farming operations in Norway and Canada, and strengthening financial position to pursue 2025 strategy
- Improve profitability
- Secure growth
- Value chain repositioning
Improvement- and growth initiatives
- Post smolt to reduce time in sea, improve biology, higher utilization of MAB and lower cost
- Time in sea below 12 months
- Increase VAP capacity
-
Farming cost/kg below NOK 40 by 2022
-
Mitigation to reduce biological risk of ISA and winter ulcers
- Change in vaccination strategy
- Change in strategy to transfer smolt to sea
- Add 4 000 tonnes of post smolt capacity by 2025
- VAP capacity to handle industry grade quality
-
Farming cost/kg below NOK 40 by 2022
-
Algae mitigation, digital monitoring and aeration systems
- Increase post smolt capacity
- Develop our business in farming areas under agreements with First Nations
- Farming cost target below CAD 7/kg
Precision Farming, centralized feeding and digitalization
Newfoundland main growth driver
- Significant growth potential, targeting 15 000 tonnes in 2025
- Strengthens exposure to the world's largest and fastest growing market for Atlantic salmon
- Synergies in integration with existing North American operations
- Gradual development to ensure biosecurity and fish health
- Plan for release of 3 million smolt in 2022, harvested in 2023 and 2024
MARKETS
Quarterly market development
| Market consumption (tonnes HOG) |
Q2 2021 | Q2 2020 | %-change | Market developments |
|---|---|---|---|---|
| EU | 247 100 | 242 000 | 2 % | |
| USA | 137 900 | 119 500 | 15 % | • Stable demand in Europe and Asia vs Q2 2020 |
| Brazil | 25 000 | 16 700 | 50 % | 2020 |
| Russia | 19 400 | 11 900 | 63 % | |
| Japan | 15 200 | 14 800 | 3 % | Norwegian salmon |
| China/ Hong Kong/ Vietnam |
26 800 | 33 100 | -19 % | |
| Other Asia | 32 400 | 26 700 | 21 % | supply in the quarter |
| Other markets | 83 000 | 77 700 | 7 % | |
| Total all markets | 586 800 | 542 400 | 8 % |
| • Demand driven by supermarkets and grocery stores |
|---|
| • Stable demand in Europe and Asia vs Q2 2020 |
| • Strong demand increase of 15% in North America vs Q2 2020 |
| • Decrease of salmon supplied by Chile and Canada pushed prices in North America and increased the demand for Norwegian salmon |
| • Salmon of Norwegian origin contributed to half of the total supply in the quarter |
Source: Kontali Analyse
Spot market price development
The NQSALMON weekly average is presented less distributor margin of NOK/KG 0.75.
Reduced supply growth in 2021
Source: Kontali Analyse AS
EXPECTED VOLUME CHANGE BY COUNTRY (1 000 tonnes WFE)
Downstream strategy supported by in house market organization
In house sales- and market organization fully operational from Q2 handling 100% of harvested volume
Objectives and results
- Improve supply chain management
- Reduce transaction costs
- Increase raw material utilization
Downstream priorities going forward
- Strengthen processing capacity evaluating external and internal opportunities
- Long term agreements with third parties
- Development of existing processing infrastructure
- Establish VAP sales department in Q3 2021
- Broaden product offering
- Value chain repositioning
- Retail and food service partnerships
- Develop a strong B2B brand through closer relationships, transparency and traceability
Repositioning from being a supplier to an innovative partner
OPERATIONS
Q2 2021 highlights
- Price achievement negatively impacted by fixed price contracts (46%) and downgrading (76% superior share), partly offset by high average harvest weight
- Farming cost per kg higher than Q2 2020 and Q1 2021 due to site specific conditions
- Expect harvest of 7 000 tonnes in Q3 2021, with stable cost per kg
- Harvest target of 28 000 tonnes in 2021
| GSF Rogaland | ||||||
|---|---|---|---|---|---|---|
| NOK million | Q2 2021 | Q1 2021 | Q2 2020 | YTD 2021 | YTD 2020 | |
| Harvest volume (tonnes GWT) | 7 783 | 5 346 | 4 527 | 13 129 | 11 471 | |
| Q2 2021 highlights | Revenues | 435.2 | 273.0 | 243.5 | 708.2 | 680.2 |
| Price achievement negatively impacted by fixed price contracts • |
Revenue/kg (NOK) | 55.9 | 51.1 | 53.8 | 53.9 | 59.3 |
| (46%) and downgrading (76% superior share), partly offset by | Farming cost/kg (NOK) | 45.8 | 41.9 | 44.9 | 44.2 | 40.8 |
| high average harvest weight | EBIT/kg (NOK) | 10.2 | 9.2 | 8.9 | 9.7 | 18.5 |
EBIT-bridge, quarter-on-quarter (NOK million)
GSF Finnmark
Q2 2021 highlights
- Price achievement negatively impacted by fixed price contracts (31%), harvest profile, low average harvest weight and downgrading (78% superior share) related to winter ulcers
- Farming cost per kg up from Q2 2020 and Q1 2021 due to lower harvest volume, winter ulcers, external harvesting and harvest logistics related to ISA
- Improved seawater production during the quarter. Measures taken to reduce risk of winter ulcers and ISA going forward
- Expect harvest of 10 000 tonnes in Q3 2021 with lower cost per kg
- Harvest target of 37 000 tonnes in 2021
| NOK million | Q2 2021 | Q1 2021 | Q2 2020 | YTD 2021 | YTD 2020 |
|---|---|---|---|---|---|
| Harvest volume (tonnes GWT) | 4 780 | 7 385 | 6 280 | 12 165 | 13 108 |
| Revenues | 232 | 313 | 325 | 544 | 672 |
| Revenue/kg (NOK) | 48.4 | 42.3 | 51.7 | 44.7 | 51.3 |
| Farming cost/kg (NOK) | 50.6 | 46.5 | 42.0 | 48.1 | 44.3 |
| EBIT/kg (NOK) | -2.2 | -4.1 | 9.8 | -3.4 | 7.0 |
Q2 2021 highlights
- Good price achievement driven by high superior share (89%)
- Farming cost per kg up from Q2 2020 due to lower harvest volume. Down from Q1 2021 due to lower mortality
- Strong biological performance
- Expect harvest of 4 700 tonnes in Q3 2021, with stable cost per kg. Cost improvements longer term
- Harvest target of 15 000 tonnes in 2021
| GSF BC | NOK million | Q2 2021 | Q1 2021 | Q2 2020 | YTD 2021 | YTD 2020 |
|---|---|---|---|---|---|---|
| Harvest volume (tonnes GWT) | 5 249 | 853 | 9 332 | 6 101 | 11 876 | |
| Q2 2021 highlights | Revenues | 348.5 | 51.8 | 479.9 | 400.3 | 658.7 |
| Revenue/kg (NOK) | 66.4 | 60.8 | 51.4 | 65.6 | 55.5 | |
| • Good price achievement driven by high superior share (89%) |
Farming cost/kg (NOK) | 58.0 | 60.2 | 52.7 | 58.2 | 53.1 |
| • Farming cost per kg up from Q2 2020 due to lower harvest volume. Down from Q1 2021 due to lower mortality |
Farming cost/kg (CAD) | 8.5 | 8.9 | 7.3 | 8.5 | 7.4 |
| EBIT/kg (NOK) | 8.4 | 1.1 | -1.3 | 7.4 | 2.3 |
Newfoundland project review
- Fully operational hatchery, nursery and smolt units
- Eight seawater licenses and one freshwater license secured, four more in application
- One cycle of freshwater farming completed. Both biology and RAS facility performed well
- Postponed smolt release following ISA-suspicion
- Plan for new release in 2022
- Mitigating measures taken
- Eggs and fish are currently growing well in Marystown facility
- Plan for further development in process
- Q2 operational cost NOK 32 million and write down NOK 13 million
FINANCIALS
Profit & loss
- Increased market prices vs Q2 2020, somewhat offset by downgraded fish and fixed price contracts
- Farming cost per kg increased vs Q2 2020 due to lower harvest volume in general, and biological challenges in Finnmark in particular
- Cost reduction expected as biological conditions are normalizing
- Post-smolt strategy expected to decrease disease outbreaks, sea lice treatment and fish handling, increasing the survival rates and reducing the overall operational costs
- Net financial items impacted positively from forex (impacted negatively in Q2 2020), offsetting the increased debt service costs YTD 2021 compared with YTD 2020
- Interests paid on loans higher in Q2 2021/YTD 2021 primarily due to bond financing, and higher margin on term loans due to temporary amended loan agreement
| Profit & loss from continued operations (NOK million) |
Q2 2021 | Q2 2020 | YTD Q2 2021 |
YTD Q2 2020 |
|---|---|---|---|---|
| Sales revenues | 1 122.1 | 1 169.4 | 1 781.9 | 2 328.1 |
| EBIT before production fee and fair value adj. of biological assets |
43.5 | 47.3 | 27.5 | 263.7 |
| Production fee | -5.0 | — | -10.1 | — |
| Fair value adjustments of biological assets | 109.8 | 47.2 | 266.3 | -464.3 |
| Net financial items | -17.0 | -91.0 | -1.9 | -148.9 |
| Profit before tax | 131.3 | 3.5 | 281.8 | -349.5 |
| Net profit for the period from continued operations |
95.9 | -6.8 | 200.3 | -274.8 |
EBIT-bridge, quarter-on-quarter (NOK million)
Movement in free liquidity 31.03.2021 to 30.06.2021 (NOK million)
Free liquidity
- Free liquidity end of Q2 2021 of NOK 900 million
- NOK 204 million in cash
- Unutilized revolving credit facility and overdrafts of NOK 690 million
- Factoring arrangement for the Norwegian sales organization commenced in Q2 2021 (initial effect of NOK 170 million)
- Sale of Shetland, expected finalized within Q4 2021
- SPA with Scottish Sea Farms Ltd, enterprise value of GBP 164 million (approx NOK 2 billion), assuming normalized working capital and to be adjusted for cash and debt
-
Transaction will positively impact the Group's free liquidity, leverage ratio and financial flexibility
-
A EBITDA as at Q2 2021
- B Biomass (at cost), inventories, trade- and other receivables, and trade payables
- C Investment (CAPEX) and other investment activity
- D Financing incl. debt service
- E Other operational items, income taxes paid, net funding of Shetland
Investments
- • Gross investments Estimated at approx. NOK 700 million full-year 2021
- • Rogaland Site and brood stock upgrade
- Finnmark Site and processing facility upgrade
- BC Gold River hatchery expansion
- Newfoundland Completion of Phase 1 for RAS facility and sea site preparations
- Shetland
Centralized feeding and site structure optimization
CAPEX 2021 by region* NOK million
Biomass WC investments (net)*
• NOK 100 million in estimated biomass net working capital investments for the rest of 2021
* Excluding Shetland in H2 2021
Financials summary
Key figures
• NIBD/harvest 28 as at 30 June 2021 (NIBD net of the enterprise value of the Shetland transaction)
Covenants
- Equity ratio 42% measured according to covenants (requirement minimum 35%)
- The leverage-ratio NIBD/EBITDA is not measured as a financial covenants through Q3 2021. Will be reported 31 December 2021 and onwards
- Sale of Shetland, expected to be finalized by Q4 2021, will have a significant positive impact on the Group's liquidity, leverage ratio and financial flexibility
Securing financial capacity
- Entered into agreement for the divestment of Shetland, enterprise value GBP 164 million (approx. 2 billion)
- Postponement of first smolt to sea in Newfoundland improves short term financial capacity
- Continuous evaluation of operational cost-saving measures
Net Interest-bearing debt (NIBD) according to covenant
OUTLOOK & CONCLUDING REMARKS
Outlook
| Sales & Market | Operations | Guiding (tonnes GWT) |
Rogaland | Finnmark | BC | GSF Group |
|---|---|---|---|---|---|---|
| Expect retail demand to stay strong and HoReCa market to open gradually In combination with tight global supply, we expect good market prices Efforts to secure VAP capacity Estimate contract share of 28% of Norwegian harvest volume for 2021 |
• Optimize production, focusing on fish health & welfare • Cautious and gradual development of Newfoundland • Finalize Shetland divestment • Expect harvest of 21 700 tonnes in Q3 2021 (ex Shetland) • Maintain target of 80 000 tonnes harvest in 2021 (ex Shetland) |
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Total 2021 Growth y-o-y |
5 350 7 780 7 000 7 870 28 000 |
7 380 4 780 10 000 14 840 37 000 37% |
850 5 250 4 700 4 200 15 000 -29% |
13 600 17 800 21 700 26 900 80 000 12% |
| 22% |
Summary of the quarter
- Agreement to sell Shetland, concentrating operations and strengthening financials to pursue long term strategy
- Strong production and good price achievement in British Columbia
- Norway impacted by downgrades, fixed price contracts and increased cost from winter ulcers and low volume
- Fully integrated sales- and market organization in place, focus on supply chain management and VAP capacity
- Underlying operational improvement, expect lower costs towards year end and through 2022
- Expect harvest of 21 700 tonnes in Q3 2021 (ex Shetland), and 80 000 tonnes for the full year 2021
UPCOMING FINANCIAL RESULTS
Q3 2021 3 November 2021 Q4 2021 16 February 2022
The Company reserves the right to make amendments to the financial calendar.
APPENDIX Q2 2021
Our approach to sustainable business
Profit & loss
| NOK 1 000 | Q2 2021 | Q2 2020 | YTD 2021 | YTD 2020 | FY 2020 |
|---|---|---|---|---|---|
| Continuing operations | |||||
| Sales revenues | 1 122 073 | 1 169 420 | 1 781 904 | 2 328 062 | 4 384 357 |
| Other income | 8 141 | 9 587 | 27 479 | 22 711 | 23 902 |
| Share of profit from associates | 176 | -1 037 | 459 | -435 | 3 350 |
| Raw materials and consumables used | -478 445 | -543 029 | -663 323 | -909 284 | -1 717 279 |
| Salaries and personnel expenses | -119 491 | -97 963 | -247 851 | -223 472 | -499 546 |
| Other operating expenses | -390 734 | -395 213 | -685 372 | -768 434 | -1 592 852 |
| EBITDA before production fee and fair value adjustment of | |||||
| biological assets | 141 721 | 141 766 | 213 295 | 449 147 | 601 932 |
| Depreciation property, plant and equipment | -96 587 | -92 938 | -182 523 | -182 340 | -360 178 |
| Amortization licenses and other intangible assets | -1 610 | -1 495 | -3 266 | -3 137 | -8 696 |
| EBIT before production fee and fair value adjustment of | |||||
| biological assets | 43 523 | 47 333 | 27 506 | 263 669 | 233 057 |
| Production fee | -5 025 | — | -10 119 | — | — |
| Fair value adjustment of biological assets | 109 814 | 47 222 | 266 277 | -464 270 | -289 705 |
| EBIT after production fee and fair value adjustment of biological assets |
148 312 | 94 555 | 283 664 | -200 601 | -56 648 |
| Net financial items | -17 042 | -91 006 | -1 875 | -148 948 | -247 792 |
| Profit before tax from continuing operations | 131 271 | 3 548 | 281 790 | -349 549 | -304 440 |
| Estimated taxation | -35 344 | -10 317 | -81 456 | 74 762 | -11 557 |
| Net profit for the period from continuing operations | 95 927 | -6 768 | 200 333 | -274 787 | -315 997 |
| Discontinued operations | |||||
| Net profit for the period from discontinued operations | 28 111 | -42 764 | 40 139 | -219 722 | -198 823 |
| Net profit for the period | 124 037 | -49 533 | 240 472 | -494 509 | -514 820 |
| Allocated to | |||||
| Controlling interests | 124 037 | -53 837 | 240 472 | -504 419 | -541 054 |
| Non-controlling interests | — | 4 304 | — | 9 910 | 26 234 |
The Income Statement is prepared for the Group's continuing operations. Comparable figures are re-presented
Comprehensive income
| NOK 1 000 | Q2 2021 | Q2 2020 | YTD 2021 | YTD 2020 | FY 2020 |
|---|---|---|---|---|---|
| Net profit for the period | 124 037 | -49 533 | 240 472 | -494 509 | -514 820 |
| Net other comprehensive income to be reclassified to profit/loss in subsequent periods |
|||||
| Currency effect on investment in subsidiaries | 30 347 | -53 183 | 40 526 | 34 700 | -50 298 |
| Currency effect on loans to subsidiaries | 15 352 | -46 357 | 23 192 | 25 198 | -23 667 |
| Cash flow hedges | — | 50 714 | — | 311 | -786 |
| Tax effect | -3 377 | -959 | -5 102 | -5 624 | 5 380 |
| Other gains or losses | — | — | — | — | — |
| Net other comprehensive income not to be reclassified to profit/loss in subsequent periods |
|||||
| Change in fair value of equity instruments | — | — | — | -433 | -433 |
| Other comprehensive income for the period, net of tax | 42 322 | -49 785 | 58 616 | 54 152 | -69 804 |
| Total comprehensive income for the period | 166 359 | -99 318 | 299 088 | -440 357 | -584 624 |
| Allocated to | |||||
| Controlling interests | 166 359 | -120 453 | 299 088 | -450 669 | -611 210 |
| Non-controlling interests | — | 21 136 | — | 10 312 | 26 586 |
Q2 2021
Financial position - assets
| NOK 1 000 | 30.06.2021 | 30.06.2020 | 31.12.2020 |
|---|---|---|---|
| Deferred tax assets | 36 340 | 56 427 | 29 293 |
| Goodwill | 657 269 | 670 604 | 638 019 |
| Licenses incl. warranty licenses | 1 533 314 | 1 621 216 | 1 508 452 |
| Other intangible assets incl. exclusivity agreement | 38 838 | 51 175 | 38 015 |
| Property, plant and equipment incl. right-of-use assets | 3 352 646 | 3 822 396 | 3 033 154 |
| Indemnification assets | 40 000 | — | 40 000 |
| Investments in associates | 87 380 | 80 635 | 84 421 |
| Other non-current receivables | 32 403 | 2 908 | 9 476 |
| Total non-current assets | 5 778 190 | 6 305 361 | 5 380 830 |
| Inventories | 111 816 | 164 793 | 78 001 |
| Biological assets excl. the fair value adjustment | 2 313 977 | 2 690 662 | 2 198 676 |
| Fair value adjustment of biological assets | 699 645 | 7 538 | 347 227 |
| Trade receivables | 213 179 | 350 898 | 179 384 |
| Other current receivables, derivatives and financial instruments | 200 077 | 294 711 | 217 258 |
| Cash and cash equivalents | 204 260 | 742 805 | 275 427 |
| Total current assets | 3 742 953 | 4 251 407 | 3 295 972 |
| Assets held for sale | 2 019 017 | 203 483 | 1 972 725 |
| Total assets | 11 540 159 | 10 760 251 | 10 649 527 |
Financial position - equity and liabilities
| NOK 1 000 | 30.06.2021 | 30.06.2020 | 31.12.2020 |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| Share capital | 453 788 | 453 788 | 453 788 |
| Treasury shares | -4 686 | -4 855 | -4 686 |
| Contingent consideration (acquisition of Grieg Newfoundland AS) | 701 535 | 701 535 | 701 535 |
| Retained earnings and other equity | 3 519 369 | 3 377 750 | 3 220 281 |
| Total controlling interests | 4 670 006 | 4 528 218 | 4 370 918 |
| Non-controlling interests | — | 49 286 | — |
| Total equity | 4 670 006 | 4 577 504 | 4 370 918 |
| Deferred tax liabilities | 1 011 018 | 942 280 | 908 958 |
| Share based payments | 9 986 | — | 491 |
| Borrowings and lease liabilities | 3 850 720 | 3 671 468 | 3 907 822 |
| Subordinated loans | — | 12 521 | — |
| Total non-current liabilities | 4 871 724 | 4 626 269 | 4 817 272 |
| Current portion of borrowings and leasing liabilities | 877 510 | 308 526 | 257 630 |
| Factoring liabilities | — | 88 366 | — |
| Trade payables | 531 179 | 595 683 | 562 848 |
| Tax payable | 444 | 182 394 | 14 791 |
| Other current liabilities, derivatives and financial instruments | 200 388 | 226 929 | 133 240 |
| Total current liabilities | 1 609 520 | 1 401 898 | 968 509 |
| Liabilities directly associated with the assets held for sale | 388 909 | 154 580 | 492 829 |
| Total liabilities | 6 870 153 | 6 182 747 | 6 278 609 |
| Total equity and liabilities | 11 540 159 | 10 760 251 | 10 649 527 |
Cash flow
| NOK 1 000 | Q2 2021 | Q2 2020 | YTD 2021 | YTD 2020 | FY 2020 |
|---|---|---|---|---|---|
| EBIT after production fee and fair value adjustment of biological assets | 148 312 | 94 555 | 283 664 | -200 601 | -56 648 |
| Depreciation and amortization | 98 198 | 94 434 | 185 789 | 185 477 | 368 874 |
| Gain/loss on sale of property, plant and equipment | -743 | 48 | -776 | -103 | 4 786 |
| Share of profit from associates | -176 | 1 037 | -459 | 435 | -3 350 |
| Fair value adjustment of biological assets | -109 814 | -47 222 | -266 277 | 464 270 | 289 705 |
| Change inventory excl. fair value, trade payables and rec. | 188 982 | 247 674 | -262 657 | -70 548 | 158 708 |
| Other adjustments | 51 316 | -12 200 | 102 227 | 24 157 | -144 756 |
| Taxes paid | -3 667 | -3 561 | -19 950 | -20 564 | -205 162 |
| Net cash flow from operating activities | 372 407 | 374 764 | 21 562 | 382 523 | 412 156 |
| Proceeds from sale of property, plant and equipment | 337 | 479 | 352 | 714 | 781 |
| Payments on purchase of property, plant and equipment | -183 507 | -191 377 | -316 321 | -275 933 | -760 089 |
| Payments on purchase of intangible assets incl. licenses | — | — | — | -58 872 | -159 066 |
| Payments on business combinations | — | -620 464 | — | -620 464 | -620 464 |
| Accumulated cash acquired in business combinations | — | 30 628 | — | 30 628 | 30 628 |
| Sale of subsidiary, deconsolidation of cash and cash equivalents | — | — | — | — | -84 754 |
| Government grant | — | — | 8 443 | — | — |
| Investment in associates and other invest. | — | 10 | -2 500 | 20 | 20 |
| Net cash flow from investing activities | -183 170 | -780 724 | -310 026 | -923 908 | -1 592 944 |
| Revolving credit facility (net draw-down/repayment) | -150 000 | 10 000 | -86 222 | 391 491 | 364 135 |
| Proceeds of long-term int. bearing debt | 1 750 | 1 018 560 | 627 399 | 1 018 560 | 1 527 493 |
| Repayment long-term int. bearing debt | — | — | -51 003 | -49 173 | -102 267 |
| Repayment bridge loan financing for the acquisition of Grieg Newfoundland | — | -600 000 | — | — | — |
| Restricted cash classification of the bridge loan financing of Grieg Newfoundland | — | 600 000 | — | — | — |
| Repayment lease liabilities | -47 349 | -46 744 | -87 962 | -91 051 | -177 931 |
| Net interest and other financial items | -47 520 | -30 888 | -99 870 | -46 221 | -132 932 |
| Net cash flow from financing activities | -243 119 | 950 929 | 302 341 | 1 223 606 | 1 478 498 |
| Net change in cash and cash equivalents | -53 882 | 544 969 | 13 876 | 682 221 | 297 710 |
| Cash and cash equivalents - opening balance | 208 016 | 280 177 | 275 427 | 214 497 | 214 497 |
| Currency translation of cash and cash equivalents | 399 | -4 041 | 2 781 | 5 197 | 1 982 |
| Proceeds sale of subsidiary, discontinued operations | — | — | — | — | 16 337 |
| Discontinued operations, other cash flow items | 49 727 | -78 300 | -87 825 | -159 111 | -255 099 |
| Cash and cash equivalents - closing balance | 204 260 | 742 805 | 204 260 | 742 805 | 275 427 |
The Cash Flow Statement is presented for the Group's continuing operations. Comparable figures are re-presented. See further information in Note 4.
Cash flow
- Net cash flow from operations NOK 372 million
- EBITDA contributed positively with NOK 142 million (NOK 142 million in Q2 2020)
- Changes in accounts inventory, accounts receivable and other receivables, and accounts payable of NOK 189 million
- Investment in working capital during Q2 2021: Effect from biomass of NOK 3 million, and effect from accounts payable of NOK 109 million
- Positive cash effect from accounts receivable and other receivables of NOK 77 million, impacted by re-establishment of factoring arrangement in Norway in Q2 2021
- Net cash flow from investment activities NOK -183 million
- Investments in property, plant and equipment of NOK 184 million
- Net cash flow from financing NOK -243 million
-
Cash management / payment made on RCF of NOK 150 million, in addition to lease payments and net interest expenses
-
Other cash flow effect of NOK 92 million
- Income taxes of NOK -4 million
- NOK 50 million financing related to the disposal group Shetland through the Group's continued operation cash pool arrangement
- Other operational cash flow items of NOK 46 million
Financials
- • In November 2020, Grieg Seafood was granted temporary amendment to financial covenants through Q3 2021. Grieg Seafood was in compliance with these temporary amended financial covenants at 30 June 2021
- On 29 June 2021, Grieg Seafood entered into an agreement with Scottish Sea Farms Ltd for the divestment of the Shetland assets. Enterprise value is GBP 164 million, expected to be completed within Q4 2021, depending on processing time with relevant competition authorities
- Shetland-transaction will positively impact the Group's liquidity, leverage ratio and financial flexibility
- Equity ratio was 40% at the end of Q2 2021, vs 42% measured according to covenants.
- NIBD at the end of Q2 2021 was NOK 4 563 million, while NIBD according to covenants was NOK 4 174 million. The leverage-ratio NIBD/EBITDA is not measured as a financial covenants through Q3 2021, and will be reported 31 December 2021 and onwards
| NIBD (NOK million)* | 30.06.2021 | 30.06.2020 | 31.12.2020 |
|---|---|---|---|
| Green bond loan | 1 500 | 1 000 | 1 500 |
| Term loan and revolving credit and other non current interest bearing liabilities |
2 513 | 2 120 | 2 023 |
| Leasing liabilities** | 756 | 883 | 685 |
| Factoring liabilities | — | 88 | — |
| Cash and loans to associates | -206 | -755 | -277 |
| NIBD | 4 563 | 3 336 | 3 931 |
| Factoring liabilities | — | -88 | — |
| Quote share of cash OQ AS (40%)*** | — | 12 | — |
| Lease liabilities (IFRS 16 effect)**** | -362 | -435 | -252 |
| Non-current debt to the Province of Newfoundland and Labrador, Canada |
-26 | — | — |
| Total adjustments to covenant | -388 | -512 | -252 |
| NIBD according to covenant | 4 174 | 2 824 | 3 679 |
*NIBD is calculated based on the Group's loan covenants, and do not include assets held for sale. **Leasing liabilities include all leasing in line with IFRS.
***Ocean Quality AS (now Sjór) has been sold. Adjustment not relevant as from 31 December 2020. ****Adjusted for the IFRS 16 effect compared to IFRS in force prior to 1 January 2019.
- • Green bond loan: Balloon in June 2025, 3M NIBOR + 3.4%
- Term loan and revolving credit facility (RCF): Semi annual installments of the NOK and EUR term loans of NOK 25 million and EUR 2.5 million with balloon in February 2023. RCF as balloon. 3M NIBOR + 3.5%
- Province of Newfoundland and Labrador, Canada
- CAD 5 million at 30 June 2021, increase in facility subject to fulfillment of set milestones of the Newfoundland-project. Interest-free until 2026, thereafter 3 %. Repayment within 2039, annual installments based on free cash flow.
Share information
Number of shares
• 113 447 042 shares incl. treasury shares
Last issues
- Q2 2020, NOK 7 million in new shares issued (contribution in kind, related to the Grieg Newfoundland-transaction)
- Q2 2009, NOK 139 million in new shares issued
Subordinated convertible bond issued in Q1 2009
- 100 million converted at NOK 4.0 per share within 31 December 2010
- 85% converted in Q2 2009, 15% in Q3 2009
Share savings program for the employees
- To strengthen culture and encourage loyalty by offering employees to become shareholders in Grieg Seafood
- Transferred 21 576 treasury shares to employees in Q4 2018
- Another 14 737 treasury shares transferred to employees in Q4 2019
- Transferred 42 193 treasury shares to employees in Q4 2020
EPS
- 0.9 NOK/share Q2 2021 (continued operations)
- -0.1 NOK/share Q2 2020 (continued operations)
- 1.8 NOK/share YTD 2021 (continued operations)
- -2.4 NOK/share YTD 2020 (continued operations)
Share price
- NOK 88.7 at quarter-end Q2 2021
- NOK 98.5 at quarter-end Q2 2020
Shareholder structure
• Largest 20 holds 76.15% of total number of shares
| THE 20 LARGEST SHAREHOLDERS IN GRIEG SEAFOOD ASA AT 30.06.2021 |
NO. OF SHARES | SHARE HOLDING |
|---|---|---|
| Grieg Aqua AS | 56 914 355 | 50.17% |
| Folketrygdfondet | 4 879 366 | 4.30% |
| OM Holding AS | 4 713 957 | 4.16% |
| Ystholmen Felles AS | 2 428 197 | 2.14% |
| State Street Bank and Trust Comp (nominee) | 1 990 821 | 1.75% |
| Clearstream Banking S.A. (nominee) | 1 892 318 | 1.67% |
| Ferd AS | 1 456 453 | 1.28% |
| The Bank of New York Mellon SA/NV (nominee) | 1 375 000 | 1.21% |
| Six Sis AG (nominee) | 1 304 109 | 1.15% |
| Banque Degroof Petercam Lux. SA (nominee) | 1 259 653 | 1.11% |
| Grieg Seafood ASA | 1 171 494 | 1.03% |
| JPMorgan Chase Bank, N.A., London (nominee) | 998 448 | 0.88% |
| Kvasshøgdi AS | 996 772 | 0.88% |
| Ronja Capital II AS | 895 004 | 0.79% |
| UBS Switzerland AG (nominee) | 864 421 | 0.76% |
| State Street Bank and Trust Comp (nominee) | 744 934 | 0.66% |
| State Street Bank and Trust Comp (nominee) | 710 873 | 0.63% |
| Verdipapirfondet Pareto Investment | 644 000 | 0.57% |
| DZ Privatbank S.A. (nominee) | 583 400 | 0.51% |
| Danske Invest Norge Vekst | 561 000 | 0.49% |
| Total 20 largest shareholders | 86 384 575 | 76.15% |
| Total others | 27 062 467 | 23.85% |
| Total number of shares | 113 447 042 | 100.00% |
4
Sales Our organization GSF Headquarters
3
2
5
| STRONG FOCUS ON IMPROVED BIOLOGICAL PERFORMANCE | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| People and routines | Post-smolt | GSF precision farming | Sea lice control | Algae prevention | Area management agreements |
||||
| • Strong competence • Advanced training programs • Strict routines and procedures • Frequent evaluation and reporting |
• More robust when placed in sea, improving survival rates • Shorter time in the sea reduces exposure to biological risks • Increased smolt release flexibility • Allows for longer fallow periods |
• Operational and strategic decision support through integrated operations centers • Improved feeding operations through IBM collaboration • Aqua Cloud project for more efficient handling of sea lice |
• Preventive measures: – Sea lice skirts, where on-site conditions permit – Cleaner fish • Aqua Cloud project for predicting sea lice levels • Invested in additional non medical treatment capacity |
• Aeration systems – Reduces risk of algal issues – Increases survival during harmful algal bloom (HAB) events • Daily water samples analyzed using sensor technology and advanced image analysis – Early identification of species, prevalence and depth distribution of algae |
• Management Agreements are important to: – Collaborate with farmers with active sites in the same areas as GSF – Reduce risk of contamination due to interconnectivity in the respective areas |
| Key metrics | FY 2018 | FY 2019 | FY 2020* | YTD 2021* | |
|---|---|---|---|---|---|
| Harvest volume | 80 000 tonnes in 2021, 130 000 tonnes in 2025 (ex Shetland) |
74 623 tonnes | 82 973 tonnes | 71 142 tonnes | 31 395 tonnes |
| Farming cost | NOK 40/kg (Norway) in 2022 CAD 7/kg (Canada) in 2022 |
NOK 43.1/kg | NOK 43.5/kg | NOK 43.3/kg CAD 8.0/kg |
NOK 46.0/kg CAD 8.5/kg |
| Financial | NIBD** /EBITDA < 4.5 Equity ratio > 35% |
1.3 47% |
1.4 46% |
n/a 41% |
n/a 40% |
| Profitability | Return on Capital Employed of 12% | 22% | 19% | 3% | —% |
| Capital structure | NIBD** /harvest volume: NOK 30/kg | NOK 22.3/kg | NOK 23.0/kg | NOK 30.9/kg | NOK 27.9/kg |
| Dividend | 30-40% of the Group's net profit after tax adjusted for fair value appraisals |
DPS NOK 4.00 Pay-out ratio*** : 68% |
DPS NOK 4.00 Pay-out ratio*** : 57% |
DPS NOK 0.00 Pay-out ratio*** : 0% |
DPS NOK 0.00 Pay-out ratio*** : 0% |
* 2020 and YTD 2021 ex Shetland. 2017-2019 not re-presented.
** NIBD according to bank covenants. Not applicable through Q3 2021. Next measurement date of NIBD/EBITDA 31 December 2021. NIBD/Harvest YTD 2021: NIBD according to covenant less enterprise value of the Shetland assets. FY2020: NIBD according to covenants less book value of the Shetland assets. Guiding for harvest volume full-year 2021 used as at YTD 2021. *** Pay-out ratio calculated on previous year's accounts